San Diego Union-Tribune

CVS HEALTH PULLING SOME COUGH-AND-COLD TREATMENTS

- BY TOM MURPHY Murphy writes for The Associated Press.

CVS Health is pulling from its shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffectiv­e by doctors and researcher­s.

The drug store chain said it will remove a small number of oral decongesta­nts that contain phenylephr­ine as the only active ingredient. CVS also said it will still sell “many other oral cough and cold products to meet consumer needs.”

A company spokeswoma­n declined to elaborate on how many products will be removed when contacted by The Associated Press Friday.

CVS Health runs more than 9,000 stores in the United States. Representa­tives of its national rival, Walgreens, has not pulled any products.

A Walgreens spokeswoma­n said the company is monitoring the situation and partnering with its clinical integrity office and suppliers “on appropriat­e next steps.”

U.S. Food and Drug Administra­tion advisers voted unanimousl­y last month against the effectiven­ess of phenylephr­ine, which is found in popular versions of Sudafed, Dayquil and other medication­s stocked on store shelves.

The FDA had asked its outside advisers to examine the longquesti­oned drug ingredient. Studies conducted in the past few years by the drugmakers Merck and Johnson & Johnson have shown no difference between phenylephr­ine medication­s and placebos for relieving congestion.

The FDA, which has not acted on the recommenda­tion of its advisers, said the drug appears more effective when applied directly to the nose, in sprays or drops. Those products are not under review.

Phenylephr­ine had become the main drug in over-thecounter decongesta­nts when medicines with an older ingredient — pseudoephe­drine — were moved behind pharmacy counters. A 2006 law had forced the move because pseudoephe­drine can be illegally processed into methamphet­amine.

Those original versions of Sudafed and other medicines remain available without a prescripti­on.

The CVS Health announceme­nt comes shortly before another cold-and-flu season starts in the United States as winter sets in. Last year, an unusually fast start to the season led to shortages of Children’s Tylenol and other medication­s customers can purchase over-the-counter, or without a prescripti­on.

Newspapers in English

Newspapers from United States